Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Labeling Proposal Should Allow "Flexible" Warnings, Merck Tells Agency

Executive Summary

Standardized headings in the "Warnings/Precautions" section of labeling would inappropriately limit manufacturer flexibility in communicating drug risk information, Merck said in comments on the agency's labeling rewrite proposed rule.

You may also be interested in...



Rx Label Format Changes Should Be Phased In Without "Highlights" - PhRMA

FDA's prescription drug labeling initiative should proceed in areas where there is consensus between the agency and the pharmaceutical industry, the Pharmaceutical Research & Manufacturers of America said in comments on the proposed rule.

Rx Label "Highlights" Under FDA Rule Could Yield Inconsistencies - Merck

Information included in the "Highlights" summary section of drug labeling under FDA's proposed rule would likely be inconsistent from product to product, Merck said in comments on FDA's proposed labeling rule.

Indication, Warning Summaries In Labeling "Highlights" - FDA Rule

The new Highlights section of labeling under FDA's proposed labeling rule would feature a summary of the product's indication rather than the indication verbatim.

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel